Cargando…

Continuing Peanut Oral Immunotherapy via Telemedicine During the COVID-19 Pandemic

Detalles Bibliográficos
Autores principales:	Schoonover, Anna, Uyehara, Anny, Goldman, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Mosby, Inc. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849492/ http://dx.doi.org/10.1016/j.jaci.2020.12.405

Ejemplares similares

Safe Subcutaneous Immunotherapy Dosing Adjustments Following Prolonged Interruptions In Therapy Due To Covid-19 Pandemic
por: Kang, Lois, et al.
Publicado: (2021)

Home-Based Peanut Oral Immunotherapy for Low-Risk Peanut-Allergic Preschoolers During the COVID-19 Pandemic and Beyond
por: Chua, Gilbert T., et al.
Publicado: (2021)

Exploring barriers to commercial peanut oral immunotherapy treatment during COVID-19
por: Leef, Chelsea, et al.
Publicado: (2022)

Oral immunotherapy for peanut allergy: The pro argument
por: Chinthrajah, R. Sharon, et al.
Publicado: (2020)

Peanut Oral Immunotherapy: a Current Perspective
por: Patrawala, Meera, et al.
Publicado: (2020)

Oral immunotherapy for peanut allergy: The con argument
por: Fiocchi, Alessandro, et al.
Publicado: (2020)

Peanut allergy: Beyond the oral immunotherapy plateau
por: Bruton, Kelly, et al.
Publicado: (2021)

Interpreting success or failure of peanut oral immunotherapy
por: Cao, Shijie, et al.
Publicado: (2022)

Transitioning peanut oral immunotherapy to clinical practice
por: Lazizi, S., et al.
Publicado: (2022)

Transitioning from epicutaneous to oral peanut immunotherapy
por: Wong, Lauren, et al.
Publicado: (2023)

Bronchial hyperresponsiveness and asthma during oral immunotherapy for egg or peanut allergy in children
por: Burman, Janne, et al.
Publicado: (2022)

Telemedicine during COVID‐19 pandemic
por: Menardi, Endrj, et al.
Publicado: (2020)

Effect of ketotifen premedication on adverse reactions during peanut oral immunotherapy
por: Jagdis, Amanda, et al.
Publicado: (2014)

Peanut immunotherapy
por: Anagnostou, Katherine, et al.
Publicado: (2014)

Peanut oral immunotherapy: current trends in clinical trials
por: Reinwald, Simone, et al.
Publicado: (2022)

Peanut oral immunotherapy may improve health‐related quality of life among severe peanut allergic adolescents
por: Ödling, Maria, et al.
Publicado: (2023)

Optimizing telemedicine encounters for oral and maxillofacial surgeons during the COVID-19 pandemic
por: Moon, Hwi Sean, et al.
Publicado: (2021)

Accuracy of Telemedicine Consultations in Oral and Maxillofacial Surgery During the COVID-19 Pandemic
por: Gangwani, Pooja, et al.
Publicado: (2023)

Ambulatory care for epilepsy via telemedicine during the COVID-19 pandemic
por: Datta, Proleta, et al.
Publicado: (2021)

Mouse strain differences in response to oral immunotherapy for peanut allergy
por: Wagenaar, Laura, et al.
Publicado: (2019)

Risk factors associated with safety of preschool peanut oral immunotherapy
por: Karunakaran, Duva, et al.
Publicado: (2023)

Optimal period for achieving sustained unresponsiveness in peanut oral immunotherapy
por: Yamashita, Kosei, et al.
Publicado: (2023)

Peanut Immunotherapy: Stepping Towards Desensitization for Peanut Allergy
por: Hsu, Joyce
Publicado: (2020)

Using Telemedicine During the COVID-19 Pandemic
por: Mahajan, Vidushi, et al.
Publicado: (2020)

Telemedicine in ophthalmology during the COVID-19 pandemic
por: Abeydeera, Asela
Publicado: (2020)

Insights into Microbiome and Metabolic Signatures of Children Undergoing Peanut Oral Immunotherapy
por: Blackman, Andrea C., et al.
Publicado: (2022)

Reduction in peanut reaction severity during oral challenge after 12 months of epicutaneous immunotherapy
por: Bégin, Philippe, et al.
Publicado: (2021)

Telemedicine in Otorhinolaryngological Practice during COVID-19 Pandemic
por: Ibekwe, Titus Sunday, et al.
Publicado: (2020)

Implications of Telemedicine in Oncology during the COVID-19 Pandemic
por: Shirke, Manasi Mahesh, et al.
Publicado: (2020)

Thyroid Cancer and Telemedicine During the COVID-19 Pandemic
por: Chablani, Sumedha V, et al.
Publicado: (2021)

Telemedicine Lessons Learned During the COVID-19 Pandemic
por: Greiwe, Justin
Publicado: (2022)

The Scope of Telemedicine in Nepal during COVID-19 Pandemic
por: Koirala, Sanjib, et al.
Publicado: (2021)

Telemedicine in heart failure during the COVID-19 pandemic
por: Martín Sánchez, Rubén Ángel, et al.
Publicado: (2023)

Early Peanut Immunotherapy in Children (EPIC) trial: protocol for a pragmatic randomised controlled trial of peanut oral immunotherapy in children under 5 years of age
por: O'Sullivan, Michael David, et al.
Publicado: (2023)

Continuing increased access to buprenorphine in the United States via telemedicine after COVID-19
por: Davis, Corey S., et al.
Publicado: (2021)

2078- Immunotherapy – 2078. Allergen-specific oral immunotherapy for peanut allergy: a Cochrane systematic review
por: Nurmatov, Ulugbek, et al.
Publicado: (2013)

Peanut oral immunotherapy in adolescents: study protocol for a randomized controlled trial
por: Michaud, Elodie, et al.
Publicado: (2015)

Peanut oral immunotherapy differentially suppresses clonally distinct subsets of T helper cells
por: Monian, Brinda, et al.
Publicado: (2022)

Children and caregiver proxy quality of life from peanut oral immunotherapy trials
por: Galvin, Audrey Dunn, et al.
Publicado: (2022)

Long-term safety and immunologic outcomes of daily oral immunotherapy for peanut allergy
por: Bird, J. Andrew, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dl6333uim7hh0g06gvf7nla5pf